The ballooning obesity drug market may have a new contender after Roche struck a $5.3 billion deal to develop Danish biotech Zealand Pharma's "next generation" weight loss drug.
from US Top News and Analysis https://ift.tt/rMjq1L8
Inside the deal: Roche and Zealand Pharma's $5.3 billion obesity drug gambit
May 03, 2025
0
